Protara Therapeutics (TARA) Cash & Equivalents (2013 - 2026)
Protara Therapeutics (TARA) posted Cash & Equivalents of $17.08 million for Q2 2026, down 45.8% from $31.5 million a year earlier but up 15.9% from the prior quarter.
Protara Therapeutics (TARA) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Protara Therapeutics' Cash & Equivalents came in at $49.66 million, down 69.5% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -21.7% (FY2020 to FY2025).
- In prior years, Protara Therapeutics' Cash & Equivalents was $162.8 million in FY2024 (+311.3%), $39.59 million in FY2023 (+64.1%), $24.13 million in FY2022 (-32.5%) and $35.72 million in FY2021 (-78.8%).
- Quarterly Cash & Equivalents has run from a low of $12.55 million in Q3 2025 to a high of $162.8 million in Q4 2024 over five years.
- On a year-over-year basis, Cash & Equivalents has declined in each of the last five quarters, with growth averaging 12.5% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2024, with growth of 311.3%; the weakest was Q1 2026, with a decline of 83.9%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $14.74 million (Q1 2026), $49.66 million (Q4 2025) and $12.55 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Protara Therapeutics | 159.53 Mn | 159.53 Mn | - | 17.08 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.08 Mn |
| Mar 31, 2026 | 14.74 Mn |
| Dec 31, 2025 | 49.66 Mn |
| Sep 30, 2025 | 12.55 Mn |
| Jun 30, 2025 | 31.50 Mn |
| Mar 31, 2025 | 91.46 Mn |
| Dec 31, 2024 | 162.80 Mn |
| Sep 30, 2024 | 51.76 Mn |
| Jun 30, 2024 | 89.58 Mn |
| Mar 31, 2024 | 52.23 Mn |
| Dec 31, 2023 | 39.59 Mn |
| Sep 30, 2023 | 33.77 Mn |
| Jun 30, 2023 | 33.98 Mn |
| Mar 31, 2023 | 21.04 Mn |
| Dec 31, 2022 | 24.13 Mn |
| Sep 30, 2022 | 47.50 Mn |
| Jun 30, 2022 | 33.82 Mn |
| Mar 31, 2022 | 25.44 Mn |
| Dec 31, 2021 | 35.72 Mn |
| Sep 30, 2021 | 40.74 Mn |
Protara Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TARA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TARA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TARA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();